These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 9164563)

  • 1. Behavioural effects in mice of subchronic chlordiazepoxide, maprotiline and fluvoxamine. II. The elevated plus-maze.
    Rodgers RJ; Cutler MG; Jackson JE
    Pharmacol Biochem Behav; 1997; 57(1-2):127-36. PubMed ID: 9164563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Behavioural effects in mice of subchronic chlordiazepoxide, maprotiline, and fluvoxamine. I. Social interactions.
    Cutler MG; Rodgers RJ; Jackson JE
    Pharmacol Biochem Behav; 1997; 57(1-2):119-25. PubMed ID: 9164562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing anxiolytic-like effects of selective serotonin reuptake inhibitors and serotonin-noradrenaline reuptake inhibitors using the elevated plus maze in mice.
    Takeuchi T; Owa T; Nishino T; Kamei C
    Methods Find Exp Clin Pharmacol; 2010 Mar; 32(2):113-21. PubMed ID: 20401348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Behavioural effects in mice of subchronic buspirone, ondansetron and tianeptine. II. The elevated plus-maze.
    Rodgers RJ; Cutler MG; Jackson JE
    Pharmacol Biochem Behav; 1997 Feb; 56(2):295-303. PubMed ID: 9050088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic treatment with duloxetine is necessary for an anxiolytic-like response in the mouse zero maze: the role of the serotonin transporter.
    Troelsen KB; Nielsen EØ; Mirza NR
    Psychopharmacology (Berl); 2005 Oct; 181(4):741-50. PubMed ID: 16032412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurochemical and behavioural characterization of milnacipran, a serotonin and noradrenaline reuptake inhibitor in rats.
    Mochizuki D; Tsujita R; Yamada S; Kawasaki K; Otsuka Y; Hashimoto S; Hattori T; Kitamura Y; Miki N
    Psychopharmacology (Berl); 2002 Jul; 162(3):323-32. PubMed ID: 12122491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Orexin-1 receptor antagonism fails to reduce anxiety-like behaviour in either plus-maze-naïve or plus-maze-experienced mice.
    Rodgers RJ; Wright FL; Snow NF; Taylor LJ
    Behav Brain Res; 2013 Apr; 243():213-9. PubMed ID: 23333844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effects of the 5-HT2 receptor antagonist on the anti-immobility effects of noradrenaline and serotonin reuptake inhibitors in the forced swimming test.
    Yamada J; Sugimoto Y
    Brain Res; 2002 Dec; 958(1):161-5. PubMed ID: 12468041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anxiolytic-like effects of antidepressants after acute administration in a four-plate test in mice.
    Hascoët M; Bourin M; Colombel MC; Fiocco AJ; Baker GB
    Pharmacol Biochem Behav; 2000 Feb; 65(2):339-44. PubMed ID: 10672988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of fluoxetine and maprotiline on functional recovery in poststroke hemiplegic patients undergoing rehabilitation therapy.
    Boyeson MG
    Stroke; 1996 Nov; 27(11):2145-6. PubMed ID: 8898832
    [No Abstract]   [Full Text] [Related]  

  • 11. The NK1 receptor antagonist NKP608 lacks anxiolytic-like activity in Swiss-Webster mice exposed to the elevated plus-maze.
    Rodgers RJ; Gentsch C; Hoyer D; Bryant E; Green AJ; Kolokotroni KZ; Martin JL
    Behav Brain Res; 2004 Sep; 154(1):183-92. PubMed ID: 15302124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prior test experience compromises the anxiolytic efficacy of chlordiazepoxide in the mouse light/dark exploration test.
    Holmes A; Iles JP; Mayell SJ; Rodgers RJ
    Behav Brain Res; 2001 Aug; 122(2):159-67. PubMed ID: 11334646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serotonin reuptake inhibitors reduce conditioned fear stress-induced freezing behavior in rats.
    Hashimoto S; Inoue T; Koyama T
    Psychopharmacology (Berl); 1996 Jan; 123(2):182-6. PubMed ID: 8741941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relations between open-field, elevated plus-maze, and emergence tests in C57BL/6J and BALB/c mice injected with GABA- and 5HT-anxiolytic agents.
    Lalonde R; Strazielle C
    Fundam Clin Pharmacol; 2010 Jun; 24(3):365-76. PubMed ID: 19735300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of noradrenaline and serotonin reuptake inhibitors on pituitary-adrenocortical and sympatho-adrenomedullar system of adult rats.
    Dronjak S; Spasojevic N; Gavrilovic L; Varagic V
    Neuro Endocrinol Lett; 2007 Oct; 28(5):614-20. PubMed ID: 17984940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of selective serotonin reuptake inhibitors on immobility time in the tail suspension test in streptozotocin-induced diabetic mice.
    Kamei J; Miyata S; Morita K; Saitoh A; Takeda H
    Pharmacol Biochem Behav; 2003 May; 75(2):247-54. PubMed ID: 12873612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of milnacipran and fluvoxamine on hyperemotional behaviors and the loss of tryptophan hydroxylase-positive cells in olfactory bulbectomized rats.
    Saitoh A; Yamaguchi K; Tatsumi Y; Murasawa H; Nakatani A; Hirose N; Yamada M; Yamada M; Kamei J
    Psychopharmacology (Berl); 2007 May; 191(4):857-65. PubMed ID: 17318509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absence of anxiolytic response to chlordiazepoxide in two common background strains exposed to the elevated plus-maze: importance and implications of behavioural baseline.
    Rodgers RJ; Davies B; Shore R
    Genes Brain Behav; 2002 Nov; 1(4):242-51. PubMed ID: 12882369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pretreatment with diazepam suppresses the reduction in defensive freezing behavior induced by fluvoxamine in the conditioned fear stress paradigm in mice.
    Miyamoto J; Tsuji M; Takeda H; Nawa H; Matsumiya T
    Eur J Pharmacol; 2000 Dec; 409(1):81-4. PubMed ID: 11099703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence of the dual mechanisms of action of venlafaxine.
    Harvey AT; Rudolph RL; Preskorn SH
    Arch Gen Psychiatry; 2000 May; 57(5):503-9. PubMed ID: 10807491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.